Skip to main content

Divita Charles III's Form 4 filing

Teladoc Health, Inc. (TDOC) · filed Sep 3, 2026

Accession no.
0001347535-26-000009
Filed
Sep 3, 2026, 4:05 PM ET
Trade date
Sep 1-2, 2026
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $115.5K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Divita Charles IIICIK 0001347535Director, Officer (CHIEF EXECUTIVE OFFICER)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 1, 2026Common StockMOption exerciseAcquired+42,277––456,899Direct
Sep 1, 2026Common StockMOption exerciseAcquired+1,966––458,865Direct
Sep 2, 2026Common StockSSaleDisposed−18,327$6.30−$115,478.43440,538Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Sep 1, 2026Common StockMOption exerciseDisposed−42,277$0.00$0253,662Direct
Sep 1, 2026Common StockMOption exerciseDisposed−1,966$0.00$011,795Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)